Amgen

Tezspire

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Amgen

Tezspire HCPCS:

J2356

HCPCS Code Descriptor:

Injection, tezepelumab-ekko, 1 mg

Category:

J Code

Tezspire NDCs:

55513-0123-01, 55513-0112-01

Primary Type:

Anti-Eosinophil Asthma

Generic/Specialty Status:

Single-Source

Package Type:

Syringe

Route of Administration:

Subcutaneous

Tezspire CPT Codes:

Potential CPT administration codes for Tezspire can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Tezspire:

Tezspire is an Anti-Eosinophil Asthma drug manufactured by Amgen and administered via the Subcutaneous route of administration. The J Code: J2356 is aligned to the drug Tezspire.

ACCESS PRICING AND MORE BY REGISTERING

J2356 Added Date:

July 1, 2022

J2356 Effective Date:

July 1, 2022

J2356 Termination Date:

HCPCS Active

Tezspire billing and coding information can be found through Amgen at the link below:
Tezspire patient assistance information can be found through TEZSPIRE Together at the URL: https://www.tezspire.com/savings-and-support.html
Tezspire prescribing information can be found at the link below:
Information regarding Tezspire’s side effects can be found at MedlinePlus